SARS-CoV-2 sero-surveillance after the first and second waves of the epidemic in Panama
Lezcano-Coba, C.; Galue, J.; Whittaker, C.; Mills, C.; de Antonio, R.; Saenz-llorens, X.; Rivera, L. F.; Rodriguez, X.; Franco, D.; Rebollon, A.; Espinosa, E.; Castillo-Castillo, C.; Martinez, A.; Martinez, M.; Leon, X.; Rios, A.; Arauz, J.; Gonzalez, P.; Dominguez, C.; Lopez-Verges, S.; Gonzalez, B.; Jimeno, J.; Valderrama, A.; Murgas, I.; Hanley, K. A.; Vasilakis, N.; Dorigatti, I.; Bueneman, M.; Faria, N. R.; Kraemer, M.; Armien, B.; Donnelly, C. A.; Carrera, J. P.
Show abstract
IntroductionIn the context of the ongoing global SARS-CoV-2 pandemic and potential future viral epidemics, seroepidemiological studies are essential for understanding epidemic dynamics. Panama, a country with a strategic geographic position that serves as a regional hub for international travel and commerce. As such, understanding local transmission patterns is critical for developing evidence based on interventions that can effectively anticipate and mitigate emerging viral threats. MethodologyWe conducted a population-based cross-sectional study in the provinces of Panama and Panama Oeste, targeting the 10 townships with the highest cumulative COVID-19 incidence. A multi-stage cluster sampling strategy was employed using the 2010 National Housing Framework. The first survey was conducted from November 30 to December 4, 2020. A follow-up survey was carried out from June 14 to July 10, 2021, to assess seroconversion and seroreversion. Serum samples were analyzed using two electrochemiluminescence immunoassays (Cobas and Vitros) to detect SARS-CoV-2-specific IgG, IgM, and IgA. We estimated the effective reproduction number (Rt) and fitted modified Poisson regression models to identify risk factors associated with seropositivity. ResultsA total of 2198 participants were recruited in the first round, and 547 were successfully followed up in the second round. SARS-CoV-2 seroprevalence increased from 24.7% (95% CI: 23.0-27.0%) in the first round to 66.2% (95% CI: 62.0 - 70.0%) in the second. The seroconversion rate was 42.9% (95% CI: 38.0 - 47.0%), while seroreversion was rare (0.9%; 95% CI: 0.3 - 2.0%). The most parsimonious multivariable model identified Indigenous ethnicity, contact with a confirmed case, cohabiting with an infected household member, and prior COVID-19 diagnosis as significant risk factors for seropositivity. In contrast, higher education, belonging to other ethnic groups, and consistent mask use at work were protective factors. ConclusionsSARS-CoV-2 transmission persisted in Panama despite strict public health interventions. Household transmission, particularly among Indigenous and socioeconomically vulnerable populations, was a major driver of infection. Higher education and adherence to preventive behaviors emerged as protective factors. These findings emphasize the importance of targeted, equity focused strategies to strengthen epidemic control in Panama and comparable settings.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Epidemiological Profile and Transmission Dynamics of COVID-19 in the Philippines 94%
- Preceding anti-spike IgG levels predicted risk and severity of COVID-19 during the Omicron-dominant wave in Santa Fe city, Argentina 94%
- Prevalence and determinants of serum antibodies to SARS-CoV-2 in the general population of the Gardena Valley 93%
Similar papers in this journal
- Increased vulnerability to SARS-CoV-2 infection among indigenous peoples living in the urban area of Manaus 94%
- Young adults vulnerability to COVID-19 in Brazil: an overview across the country 93%
- High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2: a nationwide household survey 93%
Similar papers in this journal
- Endemic and epidemic human alphavirus infections in Eastern Panama, An Analysis of Population-Based Cross-Sectional Surveys 94%
- Leptospira infection in rural areas of Urabá region, Colombia: a prospective study 93%
- Updating reproduction number estimates for mpox in the Democratic Republic of Congo using surveillance data 93%
Similar papers in this journal
- Evaluating the Risk of Conflict on Recent Ebola Outbreaks in Guinea and the Democratic Republic of the Congo 94%
- Mpox knowledge and perception in Africa: a systematic review and meta-analysis 93%
- Impact of non-pharmaceutical interventions on COVID-19 incidence and deaths: cross-national natural experiment in 32 European countries 92%
Similar papers in this journal
- High Seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers 94%
- A nationwide joint spatial modelling of simultaneous epidemics of dengue, chikungunya, and Zika in Colombia 94%
- The Long-Term Impact of COVID-19 Non-Pharmaceutical Interventions on Notifiable Infectious Diseases in Poland: A Comprehensive Analysis from 2014-2022 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.